Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20928Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Liberopoulos, E. | en |
| dc.contributor.author | Miltiadous, G. | en |
| dc.contributor.author | Elisaf, M. S. | en |
| dc.date.accessioned | 2015-11-24T19:11:26Z | - |
| dc.date.available | 2015-11-24T19:11:26Z | - |
| dc.identifier.issn | 1462-8902 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20928 | - |
| dc.rights | Default Licence | - |
| dc.subject | Cholesterol, HDL/blood | en |
| dc.subject | Cholesterol, LDL/blood | en |
| dc.subject | Clofibric Acid/analogs & derivatives/therapeutic use | en |
| dc.subject | Fibric Acids | en |
| dc.subject | Humans | en |
| dc.subject | Hyperlipidemias/complications/*drug therapy | en |
| dc.subject | Hyperthyroidism/complications/*diagnosis | en |
| dc.subject | Hypolipidemic Agents/*therapeutic use | en |
| dc.subject | Lipids/*blood | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Thyrotropin/blood | en |
| dc.subject | Thyrotropin-Releasing Hormone/diagnostic use | en |
| dc.subject | Thyroxine/blood | en |
| dc.subject | Triglycerides/blood | en |
| dc.subject | Triiodothyronine/blood | en |
| dc.title | Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/11298731 | - |
| heal.identifier.secondary | http://onlinelibrary.wiley.com/store/10.1046/j.1463-1326.2001.00133.x/asset/j.1463-1326.2001.00133.x.pdf?v=1&t=h0m76vr8&s=4fe9a9be506463617a3d898c8b6557ad07999076 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2001 | - |
| heal.abstract | It is well known that thyroid hormones modulate lipoprotein metabolism. Thus, the presence of clinical or subclinical hyperthyroidism may influence lipid parameters of dyslipidaemic patients and the efficacy of hypolipidaemic therapy. Here we present a patient with mixed hyperlipidaemia whose impressive improvement of his lipid profile following ciprofibrate administration pointed towards the diagnosis of asymptomatic underlying subclinical hyperthyroidism. | en |
| heal.journalName | Diabetes Obesity & Metabolism | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Liberopoulos-2001-Impressive lipid cha.pdf | 38.07 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
